Fluoroquinolones in the treatment of community-acquired pneumonia: <br /> Rates of prescription versus emerging resistance of pneumococci
Journal Title: Αρχεία Ελληνικής Ιατρικής - Year 2008, Vol 25, Issue 2
Abstract
Community-acquired pneumonia (CAP) is the most severe respiratory infection caused by Streptococcus pneumoniae (S. pneumoniae). The empirical treatment of CAP includes the administration of a β-lactam or/and a macrolide for a period of 7 to 10 days. However, an accelerating growth of pneumococci strains resistant to a large number of antibiotics has been observed. About 40% of S. pneumoniae strains worldwide do not respond adequately to common antimicrobial treatment. This phenomenon has emphasised the need for using new, more effective drugs in the treatment of pneumococci infections, the most important of which are the latest quinolones. The ability of fluoroquinolones to inhibit bacterial protein synthesis by affecting two different enzymes (topoisomerase II and topoisomerase IV), combined with their favorable pharmacological properties, have established them among the most effective drugs used in the treatment of numerous infections caused by not only S. pneumoniae but also by other Gram positive and Gram negative bacteria. Retrospective epidemiological studies worldwide have shown that during the last fifteen years there has been an increase of up to seven times in the prescription rate of quinolones. About 50% of that increase involves respiratory infections, with patients of over 65 years the group for whom quinolones were most commonly prescribed. Although in Greece pneumococci strains resistant to fluoroquinolones have been observed, this phenomenon is already a problem for many countries, in some of which the percentage rate of resistant strains has doubled over a short period of time. For this reason it is important to determine the indications for fluoroquinolones administration for respiratory infections, in order to minimize the possibility of new, resistant strains of S. pneumoniae to evolve under the pressure of natural selection.
Authors and Affiliations
A. Boutou, P. Argyropoulou-Pataka
Keywords
Related Articles
- EP ID EP128968
- DOI -
- Views 82
- Downloads 0
A 12-week aerobic training program reduced serum C-reactive protein in women with metabolic syndrome
OBJECTIVE It is widely accepted that individuals with metabolic syndrome present a proinflammatory state that may finally result in an increased cardiovascular risk profile. This study was designed to determine the effec...
Επίπεδο γνώσης και συμπεριφοράς<br /> ως προς τη στοματική υγεία νοσοκομειακών γιατρών του λεκανοπεδίου Αττικής <br /> <br />
ΣΚΟΠΟΣ Στόχος της εργασίας αυτής ήταν η διερεύνηση του επιπέδου των γνώσεων και της συμπεριφοράς ως προς τη στοματική υγεία νοσοκομειακών γιατρών του λεκανοπεδίου Αττικής, οι οποίοι αφενός συμμετέχουν στη διαμόρφωση των...
Gitelman syndrome
No abstract available
A case of typhoid fever with no travel history
The case is reported of typhoid fever in a healthy 25-year-old female without a history of travel outside the USA or contact with any sick person. This case highlights the importance of including enteric fever in the dif...
Ventilatory response to exercise as an independent predictor of long-term survival in chronic heart failure
OBJECTIVE Patients with chronic heart failure (CHF) present exercise-induced hyperpnea, but the predictive role of this abnormal ventilatory response in risk stratification and its pathophysiological mechanism have not b...